Any current/future new fundraising through debt or equity?

The company successfully raised Rs. 750 crores through Qualified Institutional Placement (QIP) by issuing 80.12 lakh equity shares to 36 qualified institutional buyers. The funds from this QIP will be deployed for CAPEX for Site 3 and Site 5, working capital requirements, and general corporate purposes. There is no mention of any new or upcoming fundraising through debt or equity beyond this QIP in the provided pages. The company is currently focusing on utilizing this raised capital for expansion and operational needs.

Any current/future capex/capital investment/strategic investment?

Raised Rs. 750 crores through Qualified Institutional Placement (QIP) for CAPEX on Site 3, Site 5, working capital, and general corporate purposes. Site 5: Planned CAPEX of Rs. 330 crores for large-scale and contractual exclusive manufacturing; asset turn targeted at 2X. Construction underway for Site 3++ with 3 new molecules scheduled to launch in next 12-14 months. Site 4 project initiated for strategic supply agreement with a major US oil field services company; commissioning expected to start contributing from Q4 FY24, full contribution in FY25. Investment focus on expanding R&D in

Future growth expectations in sales/revenue/volumes?

Anticipated robust growth in FY24, though raw material price crash delayed momentum to Q3-Q4 (Page 10). Expected recovery and growth in agrochemical sector demand from Q3-Q4 after current destocking phase (Page 9, 18-19). Site 3 maturity expected to generate approx. Rs. 400 crores revenue over next 2 years (Page 9-10). Launch of new products in Site 3+, Site 3++, Site 4, and Site 5 to drive growth in upcoming years (Page 5). Oil field services contract starting contribution from Q4 FY24, full impact in FY25, with 16,000 MT/year volume and Rs. 300+ crores revenue potential (Page 4, 12).

Future growth expectations in earnings/operating earnings/profits/EPS?

Q2 and Q3 expected to be challenging quarters due to agro sector slowdown and inventory destocking; recovery anticipated in Q3 and Q4. Management optimistic about normalization and growth in Q3-Q4, targeting better momentum for the year-end. Revenue target of around INR 1000 crores for FY24 is still expected, though some delay possible due to market conditions. The launch of new molecules at Site 3 and Site 3++, along with large-scale manufacturing and contractual services, to drive future revenue growth. The oil field services business, expected to contribute from Q4 FY24 and FY25, ha

Current/ Expected Orderbook/ Pending Orders?

The company has signed a Letter of Intent (LOI) with one of the top three global oil field services companies in the US. This LOI includes four strategic products with a combined volume of approximately 16,000 metric tons per year, with expected revenues north of Rs. 300 crores annually starting fiscal 2025. Partial contributions from this orderbook are expected in the last quarter of the current fiscal year. The company has also launched multiple new products across various sites, including Site 3 and Site 3++, with a pipeline expected to contribute significantly over the next 1-2 years. Site

Aether Industries LtdQ1 FY24Chemicals & Petrochemicals

Aether Industries Ltd Q1 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,581P/E: 87.4Market Cap: ₹21.0K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Yes

Order

N/A

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3

Anticipated robust growth in FY24, though raw material price crash delayed momentum to Q3-Q4 (Page 10).
Expected recovery and growth in agrochemical sector demand from Q3-Q4 after current destocking phase (Page 9, 18-19).
Site 3 maturity expected to generate approx. Rs. 400 crores revenue over next 2 years (Page 9-10).
Launch of new products in Site 3+, Site 3++, Site 4, and Site 5 to drive growth in upcoming years (Page 5).
Oil field services contract starting contribution from Q4 FY24, full impact in FY25, with 16,000 MT/year volume and Rs. 300+ crores revenue potential (Page 4, 12).
Diversification across pharma, agrochemical, material science, and oil & gas sectors to balance portfolio and stimulate growth (Page 18-19).
Long-term focus on R&D pipeline and innovation to sustain new product launches and market expansion (Pages 5, 19).

Margin guidance

Category 3

Q2 and Q3 expected to be challenging quarters due to agro sector slowdown and inventory destocking; recovery anticipated in Q3 and Q4.
Management optimistic about normalization and growth in Q3-Q4, targeting better momentum for the year-end.
Revenue target of around INR 1000 crores for FY24 is still expected, though some delay possible due to market conditions.
The launch of new molecules at Site 3 and Site 3++, along with large-scale manufacturing and contractual services, to drive future revenue growth.
The oil field services business, expected to contribute from Q4 FY24 and FY25, has strong revenue potential (over Rs. 300 crores/year) with EBITDA margins around 28-30%.
EBITDA margins maintained around 29% with focus on high-value product mix to protect profitability despite pricing pressure.
R&D pipeline and diversification into material sciences, flavor & fragrance, oil & gas sectors underpin long-term growth.
Cost advantages via solar power plant and reduced utility costs expected to support margins.

See what Aether Industries Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

Yes

The company successfully raised Rs. 750 crores through Qualified Institutional Placement (QIP) by issuing 80.12 lakh equity shares to 36 qualified institutional buyers.
The funds from this QIP will be deployed for CAPEX for Site 3 and Site 5, working capital requirements, and general corporate purposes.
There is no mention of any new or upcoming fundraising through debt or equity beyond this QIP in the provided pages.
The company is currently focusing on utilizing this raised capital for expansion and operational needs.

Order book

The company has signed a Letter of Intent (LOI) with one of the top three global oil field services companies in the US.
This LOI includes four strategic products with a combined volume of approximately 16,000 metric tons per year, with expected revenues north of Rs. 300 crores annually starting fiscal 2025.
Partial contributions from this orderbook are expected in the last quarter of the current fiscal year.
The company has also launched multiple new products across various sites, including Site 3 and Site 3++, with a pipeline expected to contribute significantly over the next 1-2 years.
Site 3 at maturity is projected to generate around Rs. 400 crores in revenue.
Contract renewals and new product launches are anticipated to pick up in Q2-Q4 of the current fiscal year, with Q2 remaining challenging.
Discussions on small acquisitions and expansion of R&D capabilities are ongoing but not finalized.

See what Aether Industries Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

Raised Rs. 750 crores through Qualified Institutional Placement (QIP) for CAPEX on Site 3, Site 5, working capital, and general corporate purposes.
Site 5: Planned CAPEX of Rs. 330 crores for large-scale and contractual exclusive manufacturing; asset turn targeted at 2X.
Construction underway for Site 3++ with 3 new molecules scheduled to launch in next 12-14 months.
Site 4 project initiated for strategic supply agreement with a major US oil field services company; commissioning expected to start contributing from Q4 FY24, full contribution in FY25.
Investment focus on expanding R&D infrastructure: plans to double R&D building and manpower within next 1-2 years.
Strategic acquisitions under preliminary discussion in US and Europe to enhance R&D capabilities and footprint, no finalization yet.
Licensing agreement with Saudi Aramco Technologies finalized for commercializing sustainable converge polyols technology.

Track Aether Industries Ltd — get its next earnings analysis in your feed

How does Aether Industries Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

ThisAether Industries Ltd

Rev 3Mar 3

See where Aether Industries Ltd sits in Chemicals & PetrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does Aether Industries Ltd rank in Chemicals & Petrochemicals?

Compare Aether Industries Ltd against every Chemicals & Petrochemicals company (Q1 FY24) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

What Aether Industries Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

POCL Enterprises Ltd (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
Deepak Nitrite Ltd (Q2 FY27)
Q2 FY27 total revenue: ₹3,091 crore, up 61% YoY (Page 1, 4, 5, 6, 10, 11) . Key investor presentation takeaways from Deepak Nitrite Ltd's Q2 FY27 investor prese
Privi Speciality Chemicals Ltd (Q2 FY27)
19,239.47 lakhs (approximately 33.9% growth). Key results statement takeaways from Privi Speciality Chemicals Ltd's Q2 FY27 results statement — and how it ranks
NOCIL Ltd (Q2 FY27)
427 crores . Key investor presentation takeaways from NOCIL Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.

Compare:vs Solar Industries vs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Aether Industries Ltd Q1 FY24 Earnings Call Analysis

Revenue guidance

Fundraise plans

Capex plans

How does Aether Industries Ltd rank in Chemicals & Petrochemicals?

Continue your research

What Aether Industries Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season